Status:

COMPLETED

Natural History and Genetic Studies of Usher Syndrome

Lead Sponsor:

National Eye Institute (NEI)

Conditions:

Retinitis Pigmentosa Syndromic

Congenital Deafness

Eligibility:

All Genders

2+ years

Brief Summary

This study will explore clinical and genetic aspects of Usher syndrome, an inherited disease causing deafness or impaired hearing, visual problems, and, in some cases, unsteadiness or balance problems...

Detailed Description

Background and objectives: The Usher syndromes are a group of clinically variable and genetically heterogeneous autosomal recessive syndromes. On the basis of clinical findings, at least three types ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Eligible participants must:
  • have documented neurosensory hearing loss and retinitis pigmentosa and fulfill the clinical characteristics for USH1, USH2 and USH3 as defined by the Usher syndrome consortium. ; OR
  • be unaffected family members of a proband with Usher s syndrome, primarily parents and siblings. Family members will be considered unaffected by history if they have had previous normal ophthalmologic and hearing examinations and if they don't have decreased night or peripheral vision.
  • EXCLUSION CRITERIA:
  • Patients will be ineligible if they:
  • had an intrauterine infection, perinatal/congenital infections, or intrauterine and birth complications. These conditions can result in damage to both the auditory or visual system.
  • have concurrent inherited or acquired conditions that affect the visual and/or auditory system and significantly alter the phenotype.
  • Both affected and unaffected individuals will be ineligible if they:
  • Are unwilling or unable to provide a blood sample or unable to undergo the study procedures.
  • Are younger than 2 years old.

Exclusion

    Key Trial Info

    Start Date :

    March 21 2005

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    April 30 2019

    Estimated Enrollment :

    249 Patients enrolled

    Trial Details

    Trial ID

    NCT00106743

    Start Date

    March 21 2005

    End Date

    April 30 2019

    Last Update

    December 12 2019

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892

    2

    Queens College of the City University of New York

    New York, New York, United States